Skip to main content

Domain

The DDNN motif is required for targeting to the cell membrane and enzyme activation.

Function

Serine-type endopeptidase involved in atrial natriuretic peptide (NPPA) and brain natriuretic peptide (NPPB) processing (PubMed:10880574, PubMed:20489134, PubMed:21288900, PubMed:21763278). Converts through proteolytic cleavage the non-functional propeptides NPPA and NPPB into their active hormones, ANP and BNP(1-32) respectively, thereby regulating blood pressure in the heart and promoting natriuresis, diuresis and vasodilation (PubMed:10880574, PubMed:20489134, PubMed:21288900, PubMed:21763278). Proteolytic cleavage of pro-NPPA also plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus (PubMed:22437503). Also acts as a regulator of sodium reabsorption in kidney (By similarity).

Isoform 2

Has weaker endopeptidase activity compared to isoform 1.

Involvement in disease

Pre-eclampsia/eclampsia 5

PEE5

A hypertensive disorder of pregnancy characterized by new hypertension (blood pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant proteinuria. It impacts 2 individuals, the mother and her child, both of whom can be severely affected. Preeclampsia is one of the causes of maternal mortality and morbidity worldwide.

None

The disease is caused by variants affecting the gene represented in this entry.

Cardiomyopathy, familial hypertrophic, 30, atrial

CMH30

An autosomal recessive heart disease characterized by enlarged and thickened left atrium, left atrial fibrosis, atrial arrhythmias, and hypertension.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

N-glycosylated; required for processing and activation.

Activated through proteolytic processing by a trypsin-like protease; cleaved into a N-terminal propeptide and an activated corin protease fragment. Different soluble forms are produced by cleavage and autocatalytic cleavage: Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment is produced by cleavage by ADAM10, while 160 kDa and 100 kDa soluble fragments are produced by autocatalytic cleavage. Cleavage by ADAM10 to produce soluble 180 kDa soluble fragment takes place after the transmembrane region and before FZ 1.

A disulfide bond links the activated corin protease fragment and the N-terminal propeptide. The disulfide bond also links the activated corin protease fragment with soluble fragments (100 kDa, 160 kDa and 180 kDa fragments).

Sequence similarities

Belongs to the peptidase S1 family.

Tissue specificity

Highly expressed in heart. Expressed in heart myocytes. Also expressed in pregnant uterus. Detected in blood, in plasma as well as in serum (at protein level).

Cellular localization

  • Cell membrane
  • Single-pass type II membrane protein
  • May easily detach from the endothelial cell membrane.
  • Isoform 2
  • Cell membrane
  • Single-pass type II membrane protein
  • Less efficiently targeted to the cell membrane compared to isoform 1.
  • Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment
  • Secreted
  • Soluble form produced following cleavage by ADAM10.
  • Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment
  • Secreted
  • Soluble form produced following autocatalytic cleavage.
  • Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment
  • Secreted
  • Soluble form produced following autocatalytic cleavage.

Alternative names

CRN, TMPRSS10, CORIN, Atrial natriuretic peptide-converting enzyme, Corin, Heart-specific serine proteinase ATC2, Pro-ANP-converting enzyme, Transmembrane protease serine 10

Target type

Proteins

Primary research area

Cardiovascular

Molecular weight

116486Da

We found 5 products in 2 categories

Primary Antibodies

Target

Application

Reactive species

Proteins & Peptides

Target

Species of origin

Search our catalogue for 'CORIN' (5)

Products

ab274320

Anti-Corin antibody [EPR23361-77]

Recombinant
RabMAb